Dr. Lawrence Elmer joined the faculty of the University of Toledo College of Medicine in 1998 where he holds the position of Associate Professor of Neurology, Medical Director of the Center for Neurological Disorders, and Director of the Parkinson's Disease and Movement Disorder Program within the Department of Neurology. He serves on multiple national Parkinson's Disease advisory boards.
He is board certified by the American Board of Psychiatry and Neurology. He has been named on the list of "Best Doctors" since 2001.
Dr. Elmer's research is primarily focused on emerging pharmacologic treatments for Parkinson's disease. He has participated as a site investigator for the Parkinson Study Group for many years and is an ad hoc reviewer for journals such as Neurology, JNNP, and Movement Disorders.
Disclosure:
Grant support received by GlaxoSmithKline.
Consultant for Valeant, Teva and Schwarz-Pharma.
Speaker's Bureau for GlaxoSmithKline, Teva, Novartis, Valeant, Vernalis, Schwarz-Pharma, Boehringer-Ingelheim and Pfizer.